A study of streptomycin blood level information of patients undergoing hemodialysis

Biopharmaceutics and Drug Disposition

Volumn 23, Issue 2, 2002, Pages 47-52

  Akaho, Eiichi ^a   Maekawa, Takashi ^a   Uchinashi, Masako ^b   Kanamori, Ryuichi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b Maekawa Urologic Clinic   (Japan)

Author keywords

Hemodialysis; Pharmacokinetics; Streptomycin

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; ASSAY; BLOOD SAMPLING; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HEMODIALYSIS; HEPATITIS; HUMAN; KIDNEY FAILURE; MALE; NERVE INJURY; OTOTOXICITY; TUBERCULOSIS;

ADULT; ALGORITHMS; ANTI-BACTERIAL AGENTS; COMPUTER SIMULATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE; MALE; MIDDLE AGED; RENAL DIALYSIS; STREPTOMYCIN;

EID: 0036094136     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.293     Document Type: Article

References (10)

1. Antituberculosis drugs
2. Effect of pyrazinamide on rifampicin kinetics in patients with tuberculosis
3. Pharmacokinetic bases for the drug - Free prevention of drug - Induced hepatitis in pulmonary tuberculosis patients
4. Pharmacokinetics and side effects of Streptomycin
5. Aminoglycoside cochlear ototoxicity
6. Ototoxic antibiotics: A review
7. Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function
8. Antibiotic therapy and renal insufficiency. Pharmacokinetics of pivampicillin, cephaloridin and streptomycin in chronic uremic patients undergoing conservative or hemodialytic treatment
9. Drug therapy in Patients Undergoing Haemodialysis Clinical Pharmacokinetic Considerations
10. Drug resistance in tuberculosis patients in Jodhpur district